- Home
- BHST vs CATX Comparison
BHST vs CATX Comparison
Compare BHST & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHST
- CATX
- Stock Information
- Founded
- BHST 2007
- CATX 1983
- Country
- BHST Canada
- CATX United States
- Employees
- BHST N/A
- CATX N/A
- Industry
- BHST
- CATX Medical/Dental Instruments
- Sector
- BHST
- CATX Health Care
- Exchange
- BHST Nasdaq
- CATX Nasdaq
- Market Cap
- BHST 216.5M
- CATX 239.0M
- IPO Year
- BHST N/A
- CATX N/A
- Fundamental
- Price
- BHST $9.25
- CATX $2.60
- Analyst Decision
- BHST Strong Buy
- CATX Strong Buy
- Analyst Count
- BHST 2
- CATX 10
- Target Price
- BHST $13.00
- CATX $12.30
- AVG Volume (30 Days)
- BHST 84.7K
- CATX 1.7M
- Earning Date
- BHST 11-24-2025
- CATX 11-10-2025
- Dividend Yield
- BHST N/A
- CATX N/A
- EPS Growth
- BHST N/A
- CATX N/A
- EPS
- BHST N/A
- CATX N/A
- Revenue
- BHST $30,192,000.00
- CATX $1,235,000.00
- Revenue This Year
- BHST $116.40
- CATX N/A
- Revenue Next Year
- BHST $55.91
- CATX N/A
- P/E Ratio
- BHST N/A
- CATX N/A
- Revenue Growth
- BHST 57.83
- CATX N/A
- 52 Week Low
- BHST $4.66
- CATX $1.60
- 52 Week High
- BHST $12.80
- CATX $12.90
- Technical
- Relative Strength Index (RSI)
- BHST 42.61
- CATX 34.54
- Support Level
- BHST $8.73
- CATX $2.60
- Resistance Level
- BHST $12.20
- CATX $2.81
- Average True Range (ATR)
- BHST 1.14
- CATX 0.36
- MACD
- BHST -0.36
- CATX -0.14
- Stochastic Oscillator
- BHST 12.97
- CATX 0.97
About BHST BioHarvest Sciences Inc. Common Stock
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.